Kromann Reumert advised Coloplast on the deal. Coloplast divested their core Skin Care product portfolio. The divestment is part of Coloplast’s strategic initiative to simplify operations...
You must be a Standard 1 Year member to access this content.
Kromann Reumert advised Orifarm and its owners, Habico, on the deal. Orifarm secured a strategic capital investment from Carlyle Global Credit. Orifarm creates access to great...
You must be a Standard 1 Year member to access this content.
Kromann Reumert advised Coloplast on the deal. Coloplast entered into an agreement to acquire Kerecis hf., an innovative, fast-growing company with a proprietary fish-skin technology platform,...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz, Kromann Reumert, Vinge, Loyens & Loeff and Fava & Associati advised Coloplast on the deal. Linklaters advised PAI Partners. Coloplast has signed an agreement...
You must be a Standard 1 Year member to access this content.
Kromann Reumert has assisted Bavarian Nordic on the deal. The Danish vaccines company Bavarian Nordic A/S has entered a funding agreement with the Danish Ministry of Health...
You must be a Standard 1 Year member to access this content.
Kromann Reumert and Sidley Austin LLP advised KKR on its purchase. Mazanti-Andersen advises the sellers. Nordic Bioscience A/S, a Danish company and world leader in biomarker...
You must be a Standard 1 Year member to access this content.
